{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:12:28Z","timestamp":1792757548338,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ygyno.2023.03.017","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T13:34:58Z","timestamp":1680788098000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes"],"prefix":"10.1016","volume":"173","author":[{"given":"Zachary P.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Rimel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Cass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.03.017_bb0005","unstructured":"American Cancer Society, \"Cancer Facts and Figures 2023,\" Atlanta: American Cancer Society, https:\/\/www.cancer.org\/cancer\/ovarian-cancer\/about\/key-statistics.html, 2023 (Accessed March 20, 2023)."},{"issue":"13","key":"10.1016\/j.ygyno.2023.03.017_bb0010","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"issue":"44","key":"10.1016\/j.ygyno.2023.03.017_bb0015","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.017_bb0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"issue":"22","key":"10.1016\/j.ygyno.2023.03.017_bb0025","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.017_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamaoncol.2018.2956","article-title":"Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.017_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13048-021-00809-w","article-title":"Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing","volume":"14","author":"Cummings","year":"2021","journal-title":"J. Ovarian Res."},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.017_bb0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate- penetrance cancer-susceptibility mutations","volume":"13","author":"Tung","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2023.03.017_bb0045","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/jnci\/djaa030","article-title":"Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D","volume":"112","author":"Yang","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ygyno.2023.03.017_bb0050","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database","volume":"67","author":"M\u00f8ller","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ygyno.2023.03.017_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.humpath.2017.06.018","article-title":"Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and\/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2","volume":"70","author":"Schoolmeester","year":"2017","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"21","key":"10.1016\/j.ygyno.2023.03.017_bb0065","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"NEJM"},{"issue":"15","key":"10.1016\/j.ygyno.2023.03.017_bb0070","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"29","key":"10.1016\/j.ygyno.2023.03.017_bb0075","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from gynecologic oncology group trial GOG-0199","volume":"32","author":"Sherman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.03.017_bb0080","author":"National Comprehensive Cancer Network"},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0085","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cncr.23554","article-title":"Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome","volume":"113","author":"Kwon","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2023.03.017_bb0090","author":"National Comprehensive Cancer Network"},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.017_bb0095","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/01.AOG.0000456325.50739.72","article-title":"Lynch syndrome","volume":"124","author":"Practice bulletin no. 147","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"15 suppl","key":"10.1016\/j.ygyno.2023.03.017_bb0100","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2020.38.15_suppl.1508","article-title":"Uptake of oophorectomy in women with findings on multigene panel testing: results from the prospective registry of multiplex testing (PROMPT)","volume":"38","author":"Domchek","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.017_bb0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2022.10.001","article-title":"Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system","volume":"167","author":"Powell","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2023.03.017_bb0110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jnci\/djx265","article-title":"Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women","volume":"110","author":"Manchanda","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2017.08.030","article-title":"Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls","volume":"147","author":"Lilyquist","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.03.017_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00066","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"1","author":"Kurian","year":"2017","journal-title":"JCO Precis. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.017_bb0135","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.017_bb0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-010-0799-x","article-title":"Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1\/2 mutation carriers","volume":"124","author":"Domcheck","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.017_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"NEJM"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.017_bb0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/his.13503","article-title":"Intra-operative evaluation of prophylactic hysterectomy and salpingo-oophorectomy specimens in hereditary gynaecological cancer syndromes","volume":"73","author":"Wong","year":"2018","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2020.02.006","article-title":"Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: a large prospective single institution experience","volume":"157","author":"Rush","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0160","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2013.10.033","article-title":"Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome","volume":"132","author":"Lachiewicz","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.017_bb0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/PAS.0b013e3182796e27","article-title":"Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome","volume":"37","author":"Karamurzin","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.03.017_bb0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PGP.0000000000000643","article-title":"Prophylactic risk-reducing hysterectomies and bilateral salpingo-oophorectomies in patients with Lynch syndrome: a clinicopathologic study of 29 cases and review of the literature","volume":"39","author":"Fedda","year":"2020","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"9","key":"10.1016\/j.ygyno.2023.03.017_bb0175","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/PAS.0000000000000684","article-title":"Pathologic findings in prophylactic and nonprophylactic hysterectomy specimens of patients with Lynch syndrome","volume":"40","author":"Bartosch","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2005.12.032","article-title":"Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients","volume":"102","author":"Pistorius","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.03.017_bb0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/his.12386","article-title":"Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing","volume":"65","author":"Downes","year":"2014","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.ygyno.2023.03.017_bb0190","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/GME.0000000000001629","article-title":"Hereditary breast cancer clinical study group, factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers","volume":"27","author":"Mejia-Gomez","year":"2020","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.ygyno.2023.03.017_bb0195","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2018.12.014","article-title":"Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits","volume":"153","author":"Gordhandas","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.03.017_bb0200","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.03.017_bb0205","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jmig.2017.04.017","article-title":"Assessing the risk of occult cancer and 30-day morbidity in women undergoing risk-reducing surgery: a prospective experience","volume":"24","author":"Bogani","year":"2017","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.03.017_bb0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2023.03.017_bb0215","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823001646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:03:49Z","timestamp":1758773029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823001646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"alternative-id":["S0090825823001646"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.017","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}